Govt tightens notes exchange norms, lowers limit to Rs 2,000

Udupi, July 1: In a concerning development, another SSLC student in Udupi district has tested positive for covid-19.

With this the number of covid-19 patients among SSLC students in the coastal district rose to three. All of them are girls.

The fresh case has been reported from Byndoor. She has already written three papers.

She had reportedly developed some of the symptoms and hence her throat swabs were sent for testing on June 30. Today she received positive report, sources said.

Bengaluru, Mar 18: Karnataka Chief Minister B S Yeddyurappa on Wednesday said that the lockdown in the state will continue till March 31st. However restaurants and hotels will remain open.

Speaking to reporters here, Yediyurappa had said, "...we need to take more stringent measures, when the US President has recommended avoiding gatherings ofmore than 10 people in his country. We will discuss in the cabinet and take all necessary measures."

Two more coronavirus cases have been registered in Bengaluru on Wednesday, 18 March, taking the total infected cases to 13, ANI reported quoting state Health Minister B Sriramulu.

Meanwhile, Dental clinics in Bengaluru have shut shop after order from Indian Dental Association and Karnataka State Denta Council. The doctors have been advised to treat the patients only if there is an emergency.

In Udupit distrcit, Section 144(3) have been imposed across the district by DC G Jagadish.

No religious events allowed, devotees should not enter temples, churches or Masjid's in groups. Tourist locations closed. Students in PGs and Hostels asked to return home.

While, schools and colleges remained shut, IT professionals and other professionals working in air- conditioned places were advised to work from home. Till Tuesday evening, 13 COVID-19 positive cases have been reported in Karnataka, including one death.

The State government had on March 13 leapt into action announcing lock-down of malls, cinema theatres, pubs and night clubs for a week.

Instructions were also given to stop all kinds of exhibitions, summer camps, conferences, fairs, marriages, sports and engagement events and birthday parties state-wide for a week from Saturday.

While, schools and colleges remained shut, IT professionals and other professionals working in air- conditioned places were advised to work from home. Till Tuesday evening, 11 COVID-19 positive cases have been reported in Karnataka, including one death.

The Ministry of External Affairs confirmed that there are 276 coronavirus infected Indians abroad - 255 in Iran, 12 in UAE, five in Italy, one each in Sri Lanka, Hong Kong SAR, Kuwait, and Rwanda.

Earlier in the day, the total number of confirmed COVID-19 cases in India neared 150, according to the Health Ministry data.

Bengaluru, Mar 28: Sun Tsu, in 'The Art of War' speaks of a skilful general who can subdue his enemy without any fighting. This constitutes the ultimate triumph which is referred to as stratagem. Today, we would need one such when we are faced with the '21-day corona challenge' for India.
Nearly four weeks back, Dr Jyothsna Rao, Dr Gururaj Rao and I sat across the OPD in the afternoon at HCG Bengaluru discussing our ongoing cancer immunology research. While on this topic, we drifted into the discussion on the coronavirus. During this engaging discussion, we wondered the similarity of the enigma between the virus and cancer. I paused to ask Dr Jyothsna and Dr Guru - how we wish we could do something against this virus.
Dr Jyothsna is a PhD from NCBS and had worked under Dr Ralph Steinman, physician and researcher from Rockefeller University, who won the Nobel Prize for his discovery of the dendritic cell and its role in adaptive immunity in 2011. Dr Gururaj is a molecular and cell biologist who did his PhD at the Chapel Hill, University of North Carolina and is the Director of iCrest.
Jyothsna while hearing our perplexing conversation on the covid intervened, "Yes, surely. I think we should take a break from cancer and focus on the innate and adaptive immunity role in COVID-19."
Thus began this sincere attempt to relook the human immune system from the eyes of the COVID-19.
We have 10 types of immune cells at the least which are widely dispersed in millions across the body. When our body is invaded by a foreign organism (bacteria, fungi or virus), these cells work with each other to destroy the invader.
Now, the question is - how do the immune cells talk to each other? They use small-molecule substances called cytokines (cyto means cells; kine means movement). There are many cytokines that are involved in work on the immune system. The most relevant for viruses are interferons.
Interferons (IFN) as the name reflects have an ability to interfere with the viral activity and stop their multiplication. These specialised signal proteins are released by our cells in response to a viral attack to forewarn other cells. They help build the antiviral proteins within the cells to kill the virus as it tries to invade the new cells.
Historically, interferons are a group of cytokines known to be potent antiviral agents against viruses and a hallmark cytokine induced by the host upon viral infections. Interferons possess unique immunoregulatory activities and are signature cytokines released by (TH1) T immune cells, which are crucial in viral infections.
As the outbreak of COVID-19 grapples us, an urgent need for finding strategies to combat the virus is growing. Coronaviruses (CoVs) are a group of RNA viruses. In patients infected with coronavirus, it was indicated that the activation of the IFN does not occur until 48 hours post-infection. Thus the delayed IFN-related antiviral response by the healthy cells leads to coronavirus evade the immune response.
Numerous studies have presented the success in defeating CoVs by the direct administration of IFNs. In a combination as a concoction, it was shown to synergistically inhibit the virus replication in vitro.
Moreover, it is understood that the earlier induction of IFNs in children although they have a less developed immune system could be the reason behind the children being least affected.
The key to success in reducing the disease fatality might be the stimulation of the immune responses to trigger IFN production at the very early stages of the disease, which might be done through the administration of IFN. Despite the evidence for the efficacy of IFNs in treating CoV-induced infections, the proper dosing and ideal timing for such interventions needs to be verified in clinical trials.
For the later stages of the diseases in advance stages where patients are on ventilator and have developed respiratory distress, we propose to utilise the mesenchymal cells derived from donor bone marrow that have been known to treat acute respiratory syndrome. Mesenchymal cells are known to possess anti-inflammatory activity and thus used often in autoimmune diseases.
With this scientific background, we have activated T cells from healthy donors, in a cGMP facility at iCrest - HCG hospital with an enriched cocktail of cytokines rich in Interferons. Injections of this cocktail we believe will result in a surge of cytokines in the body of the infected person and will boost his ability to fight the virus in the early phases. We are in the initial phases of this study and hope to be ready in the coming weeks with meaningful data on its potential utility.
Currently, it awaits government approvals (Union and state) and we have applied to central drugs authority for their initial evaluation and further directions.
As my Guru often expounded the philosophy of 'Seva' - the goal of education is knowledge, the end goal of knowledge is service. In this attempt to serve our fellow humans at this brink of unprecedented crisis, medical fraternity stands with you and promises to do our best for your safety.
We assure to exhaust every bit of our spirit in this fight against coronavirus. We have lost the sight of shores and travelled thus far, but that is the mandatory first step to cross the ocean. Are we going to succeed in this battle, is something only time will answer.